Cargando…
Treatment of Pantothenate-Kinase Neurodegeneration With Baclofen, Botulinum Toxin, and Deferiprone: A Case Report
Pantothenate kinase-associated neurodegeneration (PKAN) is a rare autosomal recessive disorder characterized by progressive motor symptoms, such as dystonia and spasticity. Classical PKAN is the most common subtype of neurodegeneration with brain iron accumulation (NBIA). Currently, there is no esta...
Autores principales: | Hameed, Marya, Siddiqui, Fatima, Khan, Muhammad Khuzzaim, Tadisetty, Sindhura, Gangishetti, Prasanna Kumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society for Neurorehabilitation
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10689866/ https://www.ncbi.nlm.nih.gov/pubmed/38047104 http://dx.doi.org/10.12786/bn.2023.16.e25 |
Ejemplares similares
-
A pilot trial of deferiprone in pantothenate kinase-associated neurodegeneration patients
por: Rohani, Mohammad, et al.
Publicado: (2018) -
Borjeson-Forssman-Lehmann Syndrome: Clinical Features and Diagnostic Challenges
por: Hameed, Marya, et al.
Publicado: (2023) -
Pantothenate kinase-associated neurodegeneration
por: Hundallah, Khalid, et al.
Publicado: (2017) -
Redesigning therapies for pantothenate kinase–associated neurodegeneration
por: Munshi, Muhammad I., et al.
Publicado: (2022) -
Pantothenate kinase-associated neurodegeneration is not a synucleinopathy
por: Li, A, et al.
Publicado: (2013)